Sort by
Keyphrases
Endocannabinoid System
100%
Schizophrenia Treatment
100%
System Potential
100%
Cannabinoid Receptor 1 (CB1R)
50%
Endocannabinoid Signaling
50%
Molecular Mechanism
33%
Schizophrenia
33%
Brain Development
33%
Epidemiological Evidence
33%
Cannabis Use
16%
Therapeutic Intervention
16%
Central Nervous System
16%
Cellular Processes
16%
Molecular Pathways
16%
Genetic Heterogeneity
16%
Genetic Risk
16%
Potential Ecological Risk
16%
Clinical Evidence
16%
Psychosis
16%
Brain Function
16%
Pharmacological Approaches
16%
Animal Behavior
16%
Human Behavior
16%
Novel Therapeutic Targets
16%
Synaptic Communication
16%
Multiple Varieties
16%
Genetically Engineered Animals
16%
Pathological Evidence
16%
Multiple Environmental Factors
16%
Pathophysiology of Schizophrenia
16%
Neuroscience
Endocannabinoid System
100%
Treatment of Schizophrenia
100%
Endocannabinoid
50%
Brain Development
33%
Central Nervous System
16%
Behavior (Neuroscience)
16%
Cannabis
16%
Cannabinoid Receptor
16%
Cannabinoid Receptor Type 1
16%
Risk Factor
16%
Pharmacology, Toxicology and Pharmaceutical Science
Endocannabinoid System
100%
Endocannabinoid
50%
Cannabinoid Receptor
33%
Clinical Study
16%
Pathophysiology
16%
Preclinical Study
16%
Cannabis
16%
Cellular Processes
16%
Genetic Risk
16%
Transgenic Animal
16%